Avinger Stock Rockets Higher After Receiving FDA Clearance for Next-Generation Pantheris

Posted in Medical Device

May 23, 2018 • 2 min read

Avinger (NASDAQ: AVGR) received welcome news today as they received received 510(k) clearance from the FDA for its next generation Pantheris® Lumivascular atherectomy system, the first-ever image-guided atherectomy device for the treatment of peripheral artery disease. As we recently wrote, the success of the next generation Pantheris will play a crucial part in Avinger's turnaround plan. ...

PROCEPT Biorobotics presents positive Aquablation data at American Urological Association annual meeting

Posted in Medical Device

May 21, 2018 • 3 min read

Yesterday, during the American Urological Association Annual Meeting (AUA), PROCEPT Biorobotics announced early data from the global Phase III WATER II (Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue) Study showing the achievement of primary safety and efficacy endpoints for Aquablation in the treatment of benign prostatic hyperplasia (BPH). ​...

Migraine Drug Could Add 10% to Amgen's Revenue

Posted in Biotech

May 21, 2018 • 2 min read

On CNBC's "Power Lunch," a Wall Street analyst stated that Amgen's recently approved migraine drug, Aimovig, could become a $2 billion business in the next five years. That revenue would equate to a 10 percent increase to Amgen's revenue as the drug provides a huge unmet need for adults who deal with migraines. ...